Participants with nephrotic syndrome in NEPTUNE Match will receive information about the PIONEER study and other clinical ...

combined groups: −5.4 mV (p < 0.001) CF = cystic fibrosis; FEV 1 = forced expiratory volume in 1 second. The classes of cystic fibrosis transmembrane conductance regulator (CFTR) mutations.

With new approvals on the horizon and the closely watched Casgevy launch picking up steam in sickle cell disease and beta ...

In this article, we take a look at five biotech companies developing potentially transformative medicines to treat cystic ...

Operator Good afternoon, and welcome to AbCellera's Q3 2024 business update conference call. My name is Tamia, and I will ...

Nuclear medicine combines structural and functional imaging, thus detecting lesions earlier than traditional methodologies. CD147 is a transmembrane glycoprotein that is expressed at very low levels ...

Ivacaftor was safe and well tolerated but did not improve clinical or cystic fibrosis transmembrane conductance regulator (CFTR)-related outcomes after 12 weeks vs placebo in patients with chronic ...

Strengthened financial position resulting from recently announced MARGENZA® transaction and previously announced receipt of milestone payment ...

Presented positive 96-week long-term eGFR stabilization data from ORIGIN Ph 2b clinical trial of atacicept in IgAN in a late-breaking oral ...

Good afternoon and welcome to AbCellera's Q3 2024 business update conference call. My name is Tamia and I will facilitate the audio portion of today's interactive broadcast. (Operator Instructions).